Johnson & Johnson

157.47
3.56 (2.31%)
At close: Apr 17, 2025, 3:59 PM
157.70
0.15%
After-hours: Apr 17, 2025, 07:58 PM EDT
2.31%
Bid 157.3
Market Cap 379.48B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) 8.99
PE Ratio (ttm) 17.52
Forward PE 14.26
Analyst Buy
Ask 158.11
Volume 8,871,413
Avg. Volume (20D) 10,189,838
Open 154.16
Previous Close 153.91
Day's Range 154.16 - 159.44
52-Week Range 140.68 - 169.99
Beta 0.48

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED co...

Sector Healthcare
IPO Date Jan 2, 1943
Employees 138,100
Stock Exchange NYSE
Ticker Symbol JNJ
Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $169, which is an increase of 7.32% from the latest price.

Stock Forecasts

Earnings Surprise

Johnson & Johnson has released their quartely earnings on Apr 15, 2025:
  • Revenue of $21.89B exceeds estimates by $323M, with 2.39% YoY growth.
  • EPS of 2.77 exceeds estimates by 0.17, with 2.21% YoY growth.
  • 2 weeks ago
    -7.59%
    Johnson & Johnson shares are trading lower after a... Unlock content with Pro Subscription
    6 months ago
    +1.55%
    Johnson & Johnson shares are trading higher after the company reported better-than-expected Q3 financial results.